Filing Flows › Impact Biomedical (IBO) › Q2 2026 › vs Q2 2025
Impact Biomedical (IBO) Q2 2026 vs Q2 2025 (year over year)
Impact Biomedical's revenue fell $4K (-57%) from $7K in Q2 2025 to $3K in Q2 2026.
Impact Biomedical, Q2 2026: revenue $3K (-57% year over year), net loss $700K, operating cash flow $470K. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $3K | $7K | −$4K | -57% |
| Other income, net | $2K | −$13.2M | $13.2M | — |
| Net loss | $700K | $14.4M | −$13.7M | -95% |
| Costs & expenses | $705K | $14.4M | −$13.7M | -95% |
| Operating costs | $705K | $1.2M | −$455K | -39% |
| Cost of revenue | $1K | $1K | $0 | 0% |
| Research & development | $76K | $75K | $1K | +1% |
| SG&A | $167K | $246K | −$79K | -32% |
| Other operating costs | $461K | $838K | −$377K | -45% |
| Operating cash sources | $1.2M | $13.7M | −$12.5M | -91% |
| Depreciation & amortization | $284K | $288K | −$4K | -1% |
| Working capital & other | $886K | $13.4M | −$12.5M | -93% |
| Net loss absorbed | $700K | $14.4M | −$13.7M | -95% |
| Operating cash flow | $470K | −$694K | $1.2M | — |
Questions
How much did Impact Biomedical's revenue grow year over year in Q2 2026?
Impact Biomedical's revenue fell $4K (-57%) from $7K in Q2 2025 to $3K in Q2 2026.